Estrabet 2mg, Estradiol Valerate, Women’s Health, Hormone Replacement Therapy, Online Pharmacy
Home About us Blog
AntiCancer Drugs DISEASES/SYMPTOMS Menstrual Control Female Hormones HORMONES FEMTECH +4

Estrabet 2mg

★★★★★
★★★★★
0

(0)

Generic For PROGYNOVA
Active Ingredient ESTRADIOL VALERATE
Strength 2MG
Manufacturer ABBOTT
Estrabet 2mg 28 tablets box packaging estradiol hormone replacement therapy online pharmacy
Estrabet 2mg 28 tablets blister pack estradiol estrogen medicine online pharmacy
Estrabet 2mg 28 tablets pink blister strips with branded box estradiol hormone therapy online pharmacy
Estrabet 2mg 28 tablets box packaging estradiol hormone replacement therapy online pharmacy
Estrabet 2mg 28 tablets blister pack estradiol estrogen medicine online pharmacy
Estrabet 2mg 28 tablets pink blister strips with branded box estradiol hormone therapy online pharmacy
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 28 TABLETS $ 0.98 $ 27.40
$ 23.29
Apply ZARVY26 (-15%)
You save $ 4.11
2 BOXES - 56 TABLETS $ 0.90
8% $ 54.80
$ 50.60
$ 43.01
Apply ZARVY26 (-15%)
You save $ 7.59
★ Best Value 3 BOXES - 84 TABLETS $ 0.84
14% $ 82.20
$ 70.60
$ 60.01
Apply ZARVY26 (-15%)
You save $ 10.59
See your savings before you checkout!
With code ZARVY26, get the lowest price on every option above.
Coupon
ZARVY26
Discount
15% OFF
Max Savings
$ 10.59 on 3 Boxes
Go to Cart →
🔒 Secure Checkout

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Estrabet 2mg is an oral estrogen replacement therapy formulated with Estradiol Valerate, a prodrug of estradiol that mimics natural human estrogen. The 2mg strength provides an effective option for treating moderate to severe estrogen deficiency, commonly observed in postmenopausal women, patients with ovarian insufficiency, or those undergoing gender-affirming hormone therapy. It supports hormonal balance, improves urogenital health, reduces vasomotor symptoms, and prevents bone mineral density loss. Additionally, it has recognized off-label use in palliative cancer care for hormone-modulating effects.

Indications & Uses

  • HORMONES & MENOPAUSAL SYMPTOMS > Menopausal Hormone Therapy
  • Prescribed to relieve vasomotor symptoms, mood instability, and insomnia in estrogen-deficient women.
  • FEMTECH > Menstrual Control
  • Useful in regulating menstrual cycles, especially for those with amenorrhea or surgically-induced menopause.
  • FEMTECH > Vaginal & Urethral Atrophy
  • Promotes vaginal epithelial restoration and reduces urinary frequency, dryness, and discomfort.
  • LIFESTYLE-RELATED DISEASES > Osteoporosis
  • Prevents postmenopausal bone density loss, offering protective benefits against fractures.
  • DISEASES/SYMPTOMS > Hypoestrogenism
  • Indicated for hormone replacement in conditions such as premature ovarian failure or gonadal dysgenesis.
  • AntiCancer Drugs > Prostate Cancer
  • Employed in androgen-deprivation therapy to suppress testosterone in hormone-sensitive tumors.
  • AntiCancer Drugs > Breast Cancer
  • Used palliatively in elderly patients with hormone-responsive breast cancers.
  • AntiCancer Drugs > Others (for off-label hormonal modulation)
  • Adopted in gender-affirming care and other protocols requiring high-dose estrogenic support.

Benefits & Effectiveness

  • HORMONES & MENOPAUSAL SYMPTOMS > Menopausal Hormone Therapy
  • Prescribed to relieve vasomotor symptoms, mood instability, and insomnia in estrogen-deficient women. Estradiol Valerate undergoes enzymatic conversion to active estradiol, binding to estrogen receptors in the hypothalamus, vagina, bone, and cardiovascular system to restore systemic estrogen function.
  • FEMTECH > Menstrual Control
  • Useful in regulating menstrual cycles, especially for those with amenorrhea or surgically-induced menopause. By modulating gonadotropin release, it supports hormonal rhythm and reproductive cycle balance.
  • FEMTECH > Vaginal & Urethral Atrophy
  • Promotes vaginal epithelial restoration and reduces urinary frequency, dryness, and discomfort. Local estrogen receptor activation improves tissue elasticity and epithelial health.
  • LIFESTYLE-RELATED DISEASES > Osteoporosis
  • Prevents postmenopausal bone density loss, offering protective benefits against fractures. Estradiol stimulates bone metabolism and counters resorption.
  • DISEASES/SYMPTOMS > Hypoestrogenism
  • Indicated for hormone replacement in conditions such as premature ovarian failure or gonadal dysgenesis. Restores hormonal homeostasis and maintains cardiovascular and skeletal integrity.
  • AntiCancer Drugs > Prostate Cancer
  • Employed in androgen-deprivation therapy to suppress testosterone in hormone-sensitive tumors. Estradiol counteracts androgen effects via receptor modulation.
  • AntiCancer Drugs > Breast Cancer
  • Used palliatively in elderly patients with hormone-responsive breast cancers. Estrogen receptor engagement alters tumor hormonal signaling.
  • AntiCancer Drugs > Others (for off-label hormonal modulation)
  • Adopted in gender-affirming care and other protocols requiring high-dose estrogenic support. Provides systemic estrogenic influence, including cholesterol regulation and tissue feminization.

Directions for Use

  • Postmenopausal Symptoms (Vasomotor)
  • Oral: 1–2 mg daily with a cyclic pattern (3 weeks on, 1 week off)
  • Transdermal Patch (Twice-weekly): Start at 0.0375–0.05 mg/day; adjust 0.025–0.1 mg/day
  • Transdermal Patch (Once-weekly): 0.025 mg/day, titratable to 0.1 mg/day
  • Topical Gel (Divigel): 0.25–1.25 mg/day applied to thigh
  • Pump Gel (Estrogel): 0.52–0.75 mg/day applied to arm
  • Spray (Evamist): 1.53 mg/spray, up to 3 sprays/day to forearm
  • Vaginal Ring (Femring): Replace every 90 days
  • Injection – Estradiol cypionate: 1–5 mg IM every 3–4 weeks
  • Injection – Estradiol valerate: 10–20 mg IM every 4 weeks
  • Atrophic Urethritis / Vaginitis
  • Topical or vaginal estrogen applied locally when site-specific; oral therapy also effective for systemic relief
  • Hypoestrogenism / Ovarian Failure
  • Oral: 1–2 mg daily long-term
  • Patches or injections may be used as alternative or supplementary routes
  • Osteoporosis Prevention
  • Oral: ≥0.5 mg/day
  • Patch (Vivelle-Dot, twice-weekly): 0.025 mg/day
  • Patch (Climara, once-weekly): 0.025 mg/day
  • Ultra-low-dose Patch (Menostar): 0.014 mg/day
  • Evaluate fracture risk before initiating estrogen therapy
  • Breast Cancer (Palliation)
  • Oral: 10 mg three times daily for at least 3 months to suppress tumor progression
  • Prostate Cancer (Palliation)
  • Oral: 1–2 mg three times daily
  • IM Estradiol Valerate: 30 mg or higher every 1–2 weeks for androgen suppression
  • General Notes
  • Use the minimum effective dose for the shortest possible duration
  • In women with a uterus, combine with progestogen to prevent endometrial hyperplasia
  • Monitor thromboembolic risk, hepatic function, and cardiovascular health
  • Therapy should be re-evaluated every 6 months for continued necessity
  • Missed Dose: Take as soon as remembered; skip if near next dose. Do not double dose.
  • Discontinuation: Gradual tapering recommended under medical supervision

Storage

  • Store below 25°C. Keep away from humidity and direct sunlight.
  • Do not remove tablets from blister until time of use.
  • Keep out of reach of children and dispose of unused medication responsibly.

Possible Side Effects

  • Common: Bloating, headache, breast tenderness, nausea
  • Occasional: Mood changes, weight fluctuation, breakthrough bleeding, skin pigmentation changes
  • Rare: Gallbladder disease, liver dysfunction, fluid retention, migraine exacerbation
  • Serious: Venous or arterial thrombosis, hypertension, stroke, endometrial hyperplasia or malignancy with prolonged unopposed estrogen use – seek immediate medical attention if chest pain, sudden vision loss, speech difficulty, or leg swelling occur
  • Monitoring Advice: Routine screening for hormone-sensitive cancers and cardiovascular markers is recommended during long-term therapy

FAQs

It is typically used cyclically, but continuous regimens may be prescribed under medical supervision.
The 2mg dose offers robust symptom control for patients with high estrogen needs, such as surgical menopause or oncologic indications.
Long-term use is possible but must be balanced with monitoring and periodic evaluation of risks versus benefits.
Yes, it is used in men as part of prostate cancer therapy or gender-affirming hormone therapy.
Some patients report relief within 1–2 weeks, though full effect may take several cycles.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.